Total Payments
$2,262
2023 Payments
$149.04
Companies
28
Transactions
128
Medicare Patients
1,223
Medicare Billing
$139,459
Payment Breakdown by Category
Food & Beverage$2,235 (98.8%)
Education$26.43 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,235 | 123 | 98.8% |
| Education | $26.43 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $393.74 | 20 | $0 (2023) |
| Relypsa, Inc. | $227.83 | 14 | $0 (2020) |
| Mallinckrodt LLC | $181.05 | 6 | $0 (2018) |
| Keryx Biopharmaceuticals, Inc. | $176.74 | 13 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $164.52 | 9 | $0 (2022) |
| Amgen Inc. | $139.79 | 8 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $115.03 | 6 | $0 (2021) |
| Fresenius USA Marketing, Inc. | $112.16 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $102.30 | 6 | $0 (2018) |
| PFIZER INC. | $95.94 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $149.04 | 8 | Horizon Therapeutics plc ($149.04) |
| 2022 | $258.47 | 13 | Horizon Therapeutics plc ($132.98) |
| 2021 | $254.06 | 14 | Horizon Therapeutics plc ($111.72) |
| 2020 | $92.84 | 6 | AstraZeneca Pharmaceuticals LP ($30.66) |
| 2019 | $312.69 | 18 | Relypsa, Inc. ($98.91) |
| 2018 | $673.36 | 33 | Mallinckrodt LLC ($134.05) |
| 2017 | $521.32 | 36 | Astellas Pharma US Inc ($87.25) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: KRYSTEXXA | ||||||
| 09/25/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: KRYSTEXXA | ||||||
| 09/07/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: KRYSTEXXA | ||||||
| 08/18/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: KRYSTEXXA | ||||||
| 07/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: KRYSTEXXA | ||||||
| 05/24/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: KRYSTEXXA | ||||||
| 04/24/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: KRYSTEXXA | ||||||
| 01/24/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: KRYSTEXXA | ||||||
| 11/17/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: KRYSTEXXA | ||||||
| 10/27/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: KRYSTEXXA | ||||||
| 09/22/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: KRYSTEXXA | ||||||
| 06/16/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: NEPHROLOGY | ||||||
| 05/24/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Nephrology | ||||||
| 05/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Diabetes | ||||||
| 05/10/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: KRYSTEXXA | ||||||
| 03/31/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: KRYSTEXXA | ||||||
| 03/21/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/21/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/21/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Nephrology | ||||||
| 02/09/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: KRYSTEXXA | ||||||
| 01/18/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEPHROLOGY | ||||||
| 11/23/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardio-renal | ||||||
| 10/21/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 369 | 413 | $340,934 | $38,309 |
| 2022 | 8 | 229 | 309 | $200,171 | $27,053 |
| 2021 | 7 | 257 | 377 | $205,959 | $32,501 |
| 2020 | 9 | 368 | 426 | $278,302 | $41,596 |
Total Patients
1,223
Total Services
1,525
Medicare Billing
$139,459
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Office | 2023 | 110 | 114 | $149,016 | $14,905 | 10.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Office | 2023 | 49 | 50 | $33,600 | $4,196 | 12.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 33 | $42,972 | $4,076 | 9.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Office | 2023 | 42 | 60 | $26,054 | $3,613 | 13.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Office | 2023 | 48 | 52 | $24,672 | $3,162 | 12.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 25 | $16,800 | $2,178 | 13.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 35 | $15,001 | $2,099 | 14.0% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 13 | 13 | $14,565 | $1,727 | 11.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Office | 2023 | 12 | 17 | $11,604 | $1,549 | 13.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 14 | $6,650 | $804.37 | 12.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 91 | $61,152 | $7,354 | 12.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 34 | $43,792 | $5,090 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 59 | $15,097 | $4,625 | 30.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 50 | 51 | $34,272 | $4,147 | 12.1% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Office | 2022 | 16 | 16 | $17,552 | $2,248 | 12.8% |
| 99217 | Hospital observation care on day of discharge | Office | 2022 | 26 | 26 | $11,986 | $1,469 | 12.3% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Office | 2022 | 11 | 14 | $8,652 | $1,118 | 12.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 18 | $7,668 | $1,003 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 119 | $29,411 | $10,933 | 37.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 51 | 108 | $72,576 | $8,523 | 11.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 71 | 71 | $47,712 | $5,809 | 12.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 30 | 30 | $38,640 | $4,298 | 11.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 16 | $2,897 | $1,140 | 39.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 19 | 19 | $8,759 | $1,083 | 12.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 14 | $5,964 | $714.06 | 12.0% |
About Dr. Mario Ruiz, MD
Dr. Mario Ruiz, MD is a Nephrology healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841281177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Ruiz, MD has received a total of $2,262 in payments from pharmaceutical and medical device companies, with $149.04 received in 2023. These payments were reported across 128 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,235).
As a Medicare-enrolled provider, Ruiz has provided services to 1,223 Medicare beneficiaries, totaling 1,525 services with total Medicare billing of $139,459. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Denton, TX
- Active Since 11/04/2005
- Last Updated 12/17/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1841281177
Products in Payments
- KRYSTEXXA (Biological) $393.74
- Veltassa (Drug) $227.83
- Auryxia (Drug) $210.70
- ACTHAR (Biological) $181.05
- JYNARQUE (Drug) $126.27
- Parsabiv (Biological) $121.60
- Velphoro (Drug) $112.16
- Rayaldee (Drug) $95.79
- Prograf (Drug) $87.25
- CHANTIX (Drug) $85.43
- LOKELMA (Drug) $82.10
- BENLYSTA (Biological) $70.71
- AURYXIA (Drug) $41.04
- SAMSCA (Drug) $38.25
- FABRAZYME (Drug) $37.69
- LUPKYNIS (Drug) $33.86
- Rituxan (Biological) $33.32
- ANDEXXA (Biological) $33.27
- SOLIRIS (Drug) $30.75
- ZEPATIER (Drug) $26.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Denton
George Rojas, Do, DO
Nephrology — Payments: $8,629
Nephrology $8,629
Dr. Mohammad Hussain, Md, MD
Nephrology — Payments: $7,002
Nephrology $7,002
Paul Cespedes, M.d, M.D
Nephrology — Payments: $3,597
Nephrology $3,597
Asad Zamann, Md, MD
Nephrology — Payments: $3,529
Nephrology $3,529
Victor Canela Samaniego, Do, DO
Nephrology — Payments: $2,297
Nephrology $2,297
Dr. Felipe Porres, Md, MD
Nephrology — Payments: $1,290
Nephrology $1,290